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RET Signaling Is Required for Survival and Normal Function
of Nonpeptidergic Nociceptors
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Small unmyelinated sensory neurons classified as nociceptors are divided into two subpopulations based on phenotypic differences,
including expression of neurotrophic factor receptors. Approximately half of unmyelinated nociceptors express the NGF receptor TrkA,
and half express the GDNF family ligand (GFL) receptor Ret. The function of NGF/TrkA signaling in the TrkA population of nociceptors
has been extensively studied, and NGF/TrkA signaling is a well established mediator of pain. The GFLs are analgesic in models of
neuropathicpain emphasizing the importanceofunderstanding thephysiological functionofGFL/Ret signaling innociceptors.However,
perinatal lethality ofRet-nullmicehasprecluded the studyof thephysiological role ofGFL/Ret signaling in the survival,maintenance, and
function of nociceptors in viable mice. We deleted Ret exclusively in nociceptors by crossing nociceptor-specific Nav1.8 Cre and Ret
conditionalmice to produceRet-Nav1.8 conditional knock-out (CKO)mice. Loss ofRet exclusively in nociceptors results in a reduction in
nociceptor number and size, indicating that Ret signaling is important for the survival and trophic support of these cells.Ret-Nav1.8CKO
mice exhibit reduced epidermal innervation but normal central projections. In addition,Ret-Nav1.8CKOmice have increased sensitivity
to cold and increased formalin-induced pain, demonstrating that Ret signalingmodulates the function of nociceptors in vivo. Enhanced
inflammation-induced pain may be mediated by decreased prostatic acid phosphatase (PAP), as PAP levels are markedly reduced in
Ret-Nav1.8 CKOmice. The results of this study identify the physiological role of endogenous Ret signaling in the survival and function of
nociceptors.
Introduction
During embryonic development, small-diameter sensory neu-
rons in the dorsal root ganglion (DRG) that are classified as no-
ciceptors express theNGF receptor TrkA and depend onNGF for
survival (Johnson et al., 1980; Crowley et al., 1994; Silos-Santiago
et al., 1995). During late embryonic and early postnatal life,
small-diameter unmyelinated nociceptors (C-fiber nociceptors)
diverge into two subpopulations (Molliver et al., 1997). One pop-
ulation continues to express TrkA. In the other population, TrkA
expression is downregulated and Ret, the signaling receptor for
the GDNF family ligands (GFLs), is upregulated. Nociceptors
that express TrkA express neuropeptides, do not bind the lectin
isolectin B4 (IB4), do not express thiamine monophosphatase
(TMP), and project to lamina I and lamina II outer (IIo) of the
dorsal horn, while nociceptors that express Ret do not typically
express neuropeptides, do bind IB4, do express TMP, and
project to lamina II inner (IIi) of the dorsal horn (Molliver et
al., 1997; Braz et al., 2002; Zylka et al., 2005). While much is
known about the role of NGF/TrkA signaling in the TrkA
population of C-fiber nociceptors, notably the well established
role of NGF/TrkA signaling in pain (Pezet and McMahon,
2006), little is known of the physiological role of GFL/Ret
signaling in the Ret population.
The GFL family includes the following: glial cell line-derived
neurotrophic factor (GDNF), neurturin (NRTN), artemin
(ARTN), and persephin (PSPN) (Airaksinen and Saarma, 2002).
The GFL receptor is a complex consisting of a signaling compo-
nent, the receptor tyrosine kinase Ret, and a ligand-binding com-
ponent, a cell surface receptor called GDNF family receptor 
(GFR1-4) (Airaksinen and Saarma, 2002). Each GFR corecep-
tor binds with high affinity to one of the four ligands and confers
ligand specificity to the receptor complex: GDNF-GFR1,
NRTN-GFR2, ARTN-GFR3, and PSPN-GFR4. Ret is the
common signaling component of all GFL receptor complexes
and is required in partnership with a GFR coreceptor to form a
functional receptor complex.
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GFL/Ret signaling influences sensory neuron survival as well
as sensory neuron structure and function in many experimental
paradigms (Bennett et al., 1998b, 2000; Airaksinen and Saarma,
2002; Ernsberger, 2008; Malin and Davis, 2008). Perinatal death
of Ret-null mice has precluded study of the physiological func-
tion of Ret in mature sensory neurons (Schuchardt et al., 1994).
To overcome this limitation, we deleted Ret exclusively in the
nonpeptidergic IB4-binding subpopulation of C-fiber nocicep-
tors by crossing mice harboring a conditional RET allele (Jain et
al., 2006) with mice expressing Cre recombinase under the so-
dium channel  subunit 1.8 promoter (Nav1.8-Cre) (Stirling et
al., 2005), which is expressed exclusively in nociceptors. Analysis
of these mice reveals that Ret is required for the survival, trophic
maintenance, and normal function of IB4 nociceptors.
Materials andMethods
Animal generation. Institution approved protocols were followed for all
animal studies. Generation of Ret conditional mice with a floxed human
RET9 allele followed by the EGFP reporter for identification of cells with
Ret deletion were generated as previously described (Jain et al., 2006). To
producemice with conditionalRet deletion in nociceptors, heterozygous
mice with one Ret-null allele (RetTGM or Ret lacz) (Enomoto et al., 2001;
Gould et al., 2008) knocked into the Ret locus were crossed with
Nav1.8Cre/mice (Stirling et al., 2005) toproducedoubleheterozygousmice
(Ret/:Nav1.8Cre/).Doubleheterozygousmicewere thencrossedwithRet
conditional mice (RetRETfloxEGFP/) to produce Ret-Nav1.8 conditional
knock-out (CKO)mice (RetRETfloxEGFP/:Nav1.8Cre/) and Ret-Nav1.8 het-
erozygous control (Het) mice (RetRETfloxEGFP/:Nav1.8Cre/). Note that
EGFPreporter expression in thesemice indicates thatCre-mediateddeletion
of the floxed allele has occurred.
Behavior testing. Behavior testing was performed using male and fe-
male mice 7–10 weeks of age. Littermates or age-matched control mice of
the appropriate genotypes were used. Ret-Nav1.8CKOmice (Ret
RETfloxEGFP/:
Nav1.8Cre/) were compared with control mice that harbor at least one
functionalRet allele in nonpeptidergic nociceptors. Controlmice include
Ret-Nav1.8 Het mice (Ret
RETfloxEGFP/:Nav1.8Cre/) or others obtained
in crosses to produce Ret-Nav1.8 CKO mice (i.e., Ret
/:Nav1.8Cre/,
Ret/:Nav1.8Cre/, RetRETfloxEGFP/:Nav1.8/ , etc.). We did not ob-
serve any significant difference betweenRet-Nav1.8Hetmice (Ret
RETfloxEGFP/:
Nav1.8Cre/) and these other control mice in behavior tests; therefore,
they were combined into a single group and are referred to as control
mice. To assess general health, mice were weighed and internal and sur-
face body temperature was recorded. The experimenter was blind to the
genotypes of the mice during data acquisition. Before testing, mice were
placed in open bottomPlexiglas boxes (5 5 10 inches) on an elevated
plastic (formalin), wire mesh (von Frey, acetone), or warmed (30°C)
glass (Hargreaves) platform for 1 h (formalin, acetone) or 2–3 h (von
Frey, Hargreaves).
Formalin test. Mice were given a subcutaneous injection of 10 l of
2.5% formaldehyde into the plantar surface of the right paw, and spon-
taneous pain behavior was recorded in 5 min bins for a total of 1 h.
Spontaneous pain behavior included shaking, flinching, or licking of the
paw as well as holding the paw in an elevated position.
Mechanical sensitivity. Mechanical sensitivity was determined using
the von Frey test. Beginning with the smallest filament and continuing
from smallest to largest calibrated von Frey filaments were pressed to the
plantar surface of the hindpaw until the filament just bent. The with-
drawal threshold is defined as the force that produces a withdrawal re-
sponse in 3 of 5 consecutive applications within one trial. The threshold
was determined in 3 trials per hindpaw with a 15 min interval between
trials. Tail mechanical sensitivity was measured with an Analgesia-Meter
(Ugo Basile; Stoelting) using amodification of the Randall–Selitto test as
previously described (Morales and Gereau, 2009). The withdrawal
thresholdwas obtained by averaging the values obtained in 3 trials, which
were separated by 15 min.
Noxious heat sensitivity (Hargreaves test). The thermal threshold was
determined bymeasuring the withdrawal latency to a radiant heat source
applied to the plantar surface of the hindpaw in 5 separate trials for each
hindpawwith a 15min interval between trials. The withdrawal threshold
was determined by averaging the withdrawal latency obtained in each of
the trials.
Cold sensitivity. Sensitivity to a cold stimulus was measured using the
acetone test. One drop of acetonewas applied to the plantar surface of the
hindpaw using a 1 ml syringe. Mice were observed for 5 min after each
acetone application. Spontaneous pain behavior (defined as above in the
formalin test) that occurred within 5 min after acetone application was
counted as a positive response. Spontaneous pain behavior that occurred
within the first 15 s after acetone applicationwas not counted, sincemost
mice had some reaction to the initial application. In addition, the
amount of time spent in pain behavior was recorded. Five trials were
performed on each hindpaw with a 5 min interval between trials.
Thermal preference (gradient). Mice were tested in a thermal gradient
apparatus with zone temperatures ranging from 9°C to 51°C as described
previously (Dhaka et al., 2007). The temperature zone in which mice
spend the most time during the 2 h test is defined as the “preferred
temperature.”
Gross motor function (rotarod). An accelerating rotarod (Ugo Basile)
was used to evaluate motor coordination and balance. Five consecutive
acceleration trials were performed with a 5 min interval between trials as
described previously (Montana et al., 2009).
Sensorimotor battery. Tests in the sensorimotor battery were used as
previously described to evaluate balance, strength, coordination, and
movement (Jain et al., 2006).
Locomotor activity (open field). Locomotor activity was measured in
an open field using a VersaMax Animal Activity Monitoring System
(AccuScan Instruments). Mice were habituated to the test room in their
cages for 1 h before testing. Locomotor activity was assessed by recording
photobeam breaks in a 42 L  42 W  30 H cm chamber for 60 min.
Total distance traveled, time spent moving, and the number of beam
breaks (horizontal activity) were calculated for the entire chamber.
Total L4 DRG neuron counts.Mice were deeply anesthetized and per-
fused with PBS followed by 4% paraformaldehyde in PBS. L4 DRGs were
removed, rinsed in PBS, and embedded in paraffin. The entire DRG was
sectioned at 8 m in the transverse plane, collected in sequence, and
stained with 0.25% cresyl violet. DRG neurons containing one or more
nucleoli were counted in every 10th section. The number of neurons
counted was multiplied by 10 to obtain the total number. Counts were
corrected for split nuclei (Silos-Santiago et al., 1995).
Immunohistochemistry. To take advantage of the EGFP reporter as a
marker for neurons in which Ret is deleted, Ret-Nav1.8 CKO mice and
Ret-Nav1.8Het control mice, each of which contain one floxed Ret allele
followed by the EGFP reporter and one Cre allele in the Nav1.8 locus,
were used in immunohistochemistry (IHC) experiments. Foot pad skin
was removed from the plantar surface of the hindpaw, immersion fixed
in Zamboni’s fixative for 2 h, rinsed in PBS, and cryoprotected in 30%
sucrose. Mice were then perfused as described above. DRG and the lum-
bar enlargement of the spinal cord were removed, rinsed in PBS, and
cryoprotected in 30% sucrose. Skin was sectioned at 30 m in a plane
perpendicular to the skin surface. Transverse sections of lumbar spinal
cord and DRG (30 and 18 m, respectively) were cut on a cryostat and
collected on slides. The following antibodies were used: rabbit anti-Ret
1:200 (IBL), rabbit anti-GFP 1:1000 (Invitrogen), rabbit anti TrkA 1:300
(Millipore), rabbit anti-III tubulin (Covance), goat anti-GFR2 and
GFR3 (1:200 and 1:50, respectively R&DSystems), and goat anti-CGRP
1:400 (Serotec). Alexa conjugated to IB4 (1:100) (Invitrogen) was used
for IB4 labeling.
Neuron counts in fluorescence-labeled DRG. To determine the percent-
age of labeled neurons relative to the number of EGFP-positive neurons,
labeled profiles and EGFP-positive profiles were counted in at least 3
randomly selected sections (separated by50 m) per DRG. To deter-
mine the total number of EGFP-, III tubulin-, or TrkA-positive neu-
rons, 18m sections of the entire DRGwere collected in series. Neurons
were counted in every fourth section, and the number of neurons was
multiplied by 4 to obtain the total number.
Epidermal innervation density. The dermal–epidermal border was
traced and the length determined using MetaMorph software. Labeled
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nerve fibers in the epidermis were counted and the fiber density (# of
fibers/unit of dermal–epidermal border) was calculated (Lindfors et al.,
2006).
TMP histochemistry. Frozen spinal cord sections (30 m) were incu-
bated for 30 min at room temperature in Tris maleate buffer containing
0.08% lead nitrate and 0.25% thiamine monophosphate chloride
(Sigma) and developed in a 1% aqueous solution of sodium sulfide (Ak-
kina et al., 2001).
Microscopy. All images were captured using an upright microscope
equipped for epifluorescence microscopy (Nikon 80i; CoolSnapES cam-
era) andwere processed usingMetaMorphorAdobePhotoshop software
using global adjustments in brightness and contrast.
Quantitative real-time PCR. RNA was purified from lumbar DRG
from adult Ret-Nav1.8 CKO and control mice. RNA (1 g) was reverse
transcribed using M-MLV Reverse Transcriptase (Invitrogen). Quanti-
tative real-time PCR (qRT-PCR) was performed using Fast SYBR Green
Master Mix (Applied Biosystems), and reactions were run in an Applied
Biosystems 7900HTReal Time Thermal Cycler. All reactions were run in
triplicate, and relative fold changes in RNA amount were calculated by
the CT method using GAPDH to normalize samples (Livak and
Schmittgen, 2001).
Real-time PCR (qRT-PCR) primer sequences are as follows (533):
RET: F, ACACCTTCGGACTCACTGCT; R, CAGGGGTGTCTCCTCT-
TCTG; GAPDH: F, TGCCCCCATGTTTGTGATG; R, TGTGGTCAT-
GAGCCCTTCC; prostatic acid phosphatase (PAP): F, CTCGAAA-
TATACCTGAGTCCATGCT; R, TGGGAGCTTGAATGTCTACGTTTT.
The TRPA1 primer sequence has been previously described by Elitt et al.
(2006), and the TRPM8 and TRPV1 primer sequences have been previ-
ously described by Albers et al. (2006).
Statistical analysis.Data are reported as the mean SEM. Statistically
significant differences were determined using the Student’s t test.
Results
Specific and efficient conditional deletion of Ret in
nonpeptidergic nociceptors
Tissue-specific conditional deletion of genes is a powerful strat-
egy to study the function of genes whose embryological loss re-
sults in lethality. Ret loss results in perinatal death due to renal
agenesis (Schuchardt et al., 1994). We reasoned that generating
mice expressing a conditional RET allele (RETfloxEGFP) and the
nociceptor-specificNav1.8 Cre would allow us to study the func-
tion of Ret specifically in these neurons. We first determined
whether Cre expressed from the Nav1.8 locus could delete the
conditional RET allele in an efficient and specific manner. We
generated compound heterozygous mice that harbor one RET
conditional allele and one Nav1.8 Cre allele (RetRETfloxEGFP/:
Nav1.8Cre/, “” denotes the endogenous wild-type mouse al-
lele). This strategy allows simultaneous visualization of the
excised allele by direct detection of EGFP signal and fluorescence-
labeled markers (including Ret) for nonpeptidergic nociceptors
(Jain et al., 2006). In spinal cord and DRG from RetRETfloxEGFP/:
Nav1.8Cre/postnatal day (PND) 1mice, EGFP signal is restricted
to DRG neurons and to afferents in the superficial lamina of the
dorsal horn where small-diameter DRG neurons terminate, sug-
gesting specific deletion of Ret in nonpeptidergic nociceptors
(Fig. 1A,C,D). EGFP is not detected in motor neurons in the
ventral horn of the spinal cord or in sympathetic ganglia in these
mice, sites where Ret is known to be expressed, as shown by EGFP
signal in Ret-EGFP reporter mice that express EGFP in all Ret-










Figure 1. The conditional Ret allele is deletedwith high efficiency and specificity in nonpeptidergic nociceptors by Cre expressed from the Nav1.8 locus. A, C,D, Transverse sections of spinal cord
and DRG fromPND 0mice showing EGFP expression restricted to the DRG (A) and to afferents in the superficial laminae of the dorsal horn (C) and no EGFP inmotor neurons (D) in the Ret-Nav1.8Het
mouse.B, E, F, EGFP expression in DRG neurons (B), motor neurons in the ventral horn (F ), and cell bodies in the dorsal horn (E) of the Ret EGFP/ reportermouse.G–I, PND 1 DRG from a Ret-Nav1.8
Het mouse showing virtually complete overlap of EGFP expression (G) with IB4 label (H ). Images in G–I are representative of 3 mice. Scale bars: A, B, 100m; G–I, 30m.
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observed EGFP expression in spinal
dorsal horn neurons in Ret-EGFP re-
porter mice (Fig. 1B,E) that is absent in
Ret-Nav1.8 CKO mice (Fig. 1A,C).
These results suggest specific deletion
of the RET conditional allele in small-
diameter nociceptors.
We determined the efficiency of con-
ditional Ret deletion in small-diameter
DRG neurons using IB4 labeling, which
overlaps virtually completely with Ret in
small-diameter nonpeptidergic DRG neu-
rons (Molliver et al., 1997; Bennett et al.,
1998b). IB4 labeling in lumbar DRG from
PND1Ret-Nav1.8Hetmice (Ret
RETfloxEGFP/:
Nav1.8Cre/) reveals specific and efficient
deletion of Ret in IB4-labeled neurons
(Fig. 1G–I). Of 560 neurons expressing
EGFP (neurons from which Ret is deleted
allowing expression of the EGFP reporter
from the Ret locus), 557 were labeled with
IB4, indicating 99% specificity of Ret
deletion in the IB4 binding population
(n 3). Of 603 IB4-positive neurons, 562
express EGFP, indicating that Ret is ex-
cised from 93% of IB4-positive DRG neu-
rons (n  3). These results indicate that
Ret is deleted with high efficiency and
specificity in the population of small-
diameter DRG neurons that bind IB4
(nonpeptidergic nociceptors).
We next generated Ret-Nav1.8 CKO
mice (RetRETfloxEGFP/:Nav1.8Cre/). Ret-
Nav1.8 CKO mice were viable, grew nor-
mally to adulthood, and were grossly
indistinguishable from control littermates
that harbor at least one functional Ret al-
lele in nonpeptidergic nociceptors. There
was no difference in adult body weight or
in internal or surface body temperature betweenRet-Nav1.8CKO
and controlmice, consistent with equivalent general health of the
two groups (data not shown).
To confirm thatRet is deleted from small-diameter DRGneu-
rons (nociceptors), lumbar DRGs from adult Ret-Nav1.8 CKO
andWTmice were labeled with antibodies to Ret (Fig. 2A,B). In
WTDRG,Ret is observed in both large- and small-diameterDRG
neurons (Fig. 2A). In Ret-Nav1.8 CKO mice, Ret labeling is ab-
sent in small-diameter neurons but remains in large-diameter
neurons (Fig. 2B). Ret labeling in DRG from PND 10 Ret-Nav1.8
CKO mice shows no overlap between EGFP signal (neurons in
which Ret is deleted) and Ret immunoreactivity, indicating spe-
cific deletion of Ret from nonpeptidergic nociceptors (Fig. 2C–
E). As expected, qRT-PCR shows a significant decrease in Ret
expression in lumbar DRG from Ret-Nav1.8 CKO mice com-
pared to control mice (Table 1).
Ret regulates nociceptor survival and size
While GFLs promote survival and provide trophic support to
many types of neurons, the physiological role of Ret in small
nociceptive DRG neurons has not been examined in adult ani-
mals and remains unclear. Studies in GFL- and Gfr coreceptor-
null mice have reported variable results (Airaksinen and Saarma,
2002). To determine whether Ret is required for survival and
trophic support of nociceptors, we compared the total number of
L4 DRG neurons in adult Ret-Nav1.8 CKO mice and control
mice. We found a 33% decrease in the total number of L4 DRG
neurons inRet-Nav1.8CKOmice compared to controlmice (Fig.
3A–C). Because small-diameter nonpeptidergic nociceptors are a
subset of totalDRGneurons,we investigated the extent of neuron
loss in the EGFP-positive subpopulation of DRG neurons by
counting the total number of EGFP-positive cells. There is a 52%
decrease in the number of EGFP-positive L4 DRG neurons in
Ret-Nav1.8 CKOmice compared to Ret-Nav1.8Het control mice
(Fig. 3D–F).
To determinewhether neuron loss in the population of EGFP-
positive neurons accounts for the cell loss observed in total
neuron counts (33% above), we counted EGFP- and III
Figure 2. Ret expression is not detected in small-diameter DRG neurons in Ret-Nav1.8 CKO mice. A, B, DRG from a PND 60 WT
mouse (A) andaRet-Nav1.8CKOmouse (B) labeledwithananti-Ret antibody showing loss ofRet exclusively in small-diameterDRG
neurons in the Ret-Nav1.8 CKO mouse (B). Photographs are representative of the staining pattern observed in three mice of each
genotype. C–E, DRG from a PND 10 Ret-Nav1.8 CKO mouse showing no overlap of EGFP (C) with anti-Ret antibody (D). Merged
image of C and D is shown in E. There are two cells in E in which EGFP and Ret appear to overlap. The cell on the right is a
large-diameter Ret-positive neuron with an EGFP-positive neuron on top of it. It can be seen that EGFP is not present in the same
cell, since the EGFP label fills a smaller area than the Ret label. In addition, the cells are not in the same plane of focus. The cell on
the left is not EGFP positive, but exhibits autofluorescence, which is clearly different from the very bright EGFP labeling seen in the
cell immediately to the left. Scale bars: (in B) A, B, 20m; (in E) C–E, 30m.
Table 1. Relative changes in gene expression determined by qRT-PCR






n 3 Ret-Nav1.8 CKO mice and 5 control mice. *p	 0.05; **p	 0.001.
3986 • J. Neurosci., March 17, 2010 • 30(11):3983–3994 Golden et al. • Ret Function in Nociceptors
tubulin-positive neurons to determine the percentage of total
DRGneurons that are EGFPpositive (Table 2). InRet-Nav1.8Het
mice, EGFP-positive neurons account for 46.7  2.5% of total
DRG neurons. Loss of 52% of EGFP-positive neurons would
therefore correspond to a
24% decrease
in total neuron number, accounting for
most if not all of the DRG neuron loss in
Ret-Nav1.8 CKO mice.
The soma size ofDRGneurons is influ-
enced by the expression of GFL ligands
and GFL coreceptors (Zwick et al., 2002;
Elitt et al., 2006; Lindfors et al., 2006). We
compared the soma area of EGFP-positive
DRG neurons in Ret-Nav1.8 CKO and
Ret-Nav1.8Het control mice to determine
whether Ret signaling is required for tro-
phic support of nonpeptidergic nocicep-
tors. We found a 39% decrease in the
soma area of EGFP-positiveDRGneurons
in adult Ret-Nav1.8 CKO mice compared
to Ret-Nav1.8 Het control mice (Fig.
3D,E,G). Size frequency analysis of EGFP-
positive neurons suggests that size is de-
creased across the entire population of
EGFP-positive neurons (Fig. 3H). These
results indicate that Ret signaling is re-
quired for trophicmaintenance ofmature
nonpeptidergic DRG neurons and is in
agreement with findings in adult Gfr2-
null and PND 14 Ret-Wnt1 CKO mice
(Lindfors et al., 2006; Luo et al., 2007).
Ret regulates expression of Gfr3 in
nonpeptidergic nociceptors
In the DRG, Gfr2 and Gfr3 expression
is largely restricted to small-diameter neu-
rons, while Gfr1 is expressed in both
large-diameter and small-diameter DRG
neurons (Bennett et al., 1998b; Orozco et
al., 2001; Stucky et al., 2002; Lindfors et
al., 2006; Luo et al., 2007). Because it has
been reported that Gfr2 deletion alters
sensory function (Stucky et al., 2002;
Lindfors et al., 2006) and Ret alters Gfr2
expression (Luo et al., 2007), we exam-
inedGfr2 expression inRet-Nav1.8CKO
mice. We also examined expression of
Gfr3, the other Gfr coreceptor expressed
exclusively in small-diameterDRGneurons
(Orozco et al., 2001; Elitt et al., 2006). In
agreement with previous reports (Bennett
et al., 1998b; Lindfors et al., 2006; Luo et al., 2007), we found that
virtually all Gfr2-positive neurons in Ret-Nav1.8 Het control
mice are also EGFP positive (express Ret) and the majority of
EGFP-positive neurons coexpress Gfr2 (Table 2). Deletion of
Ret had no effect on the percentage of EGFP-positive neurons
that coexpress Gfr2, suggesting that Gfr2 expression is not
regulated by Ret in nonpeptidergic nociceptors (Table 2). The
percentage of Gfr2-positive neurons that express EGFP is sig-
nificantly less in Ret-Nav1.8 CKO mice than in Ret-Nav1.8 Het
control mice, likely reflecting the loss of EGFP neurons in Ret-
Nav1.8CKOmice. Surprisingly, we did not find extensive overlap
between EGFP (Ret) and GFR3 in Ret-Nav1.8Het control mice
(Fig. 3 I,K, Table 2). This is in contrast to previous reports, which
have found greater colocalization of Ret andGfr3 (Orozco et al.,
2001; Luo et al., 2007).We donot believe that our failure to detect



































































































































Figure 3. The number and size of nonpeptidergic nociceptors is decreased in Ret-Nav1.8 CKO mice. A–C, The total number of
neurons is decreased in the L4 DRG of adult Ret-Nav1.8 CKOmice (B, C; n 4) compared to controlmice (A, C; n 8) (*p	 0.05).
D–F, The number of EGFP-positive DRG neurons is decreased in L4 DRG of Ret-Nav1.8 CKOmice (E, F ) compared to Ret-Nav1.8 Het
controlmice (D,F ) (F,n3of each; *p0.01).D,E,G,H, The somaareaof EGFP-positiveDRGneurons is decreased inRet-Nav1.8
CKO mice (E) compared to Ret-Nav1.8 Het control mice (D) (G, n 3 of each; *p	 0.05). H, Size frequency analysis of EGFP-
positive neurons. I–K, EGFP (Ret) and GFR3 do not overlap extensively in lumbar DRG of Ret-Nav1.8Het controlmice (I ). Overlap
of EGFP and GFR3 is also not extensive in Ret-Nav1.8 CKO mice (J ) but is significantly increased compared to Ret-Nav1.8 Het
control mice (K, n 4 Ret-Nav1.8 CKOmice, n 5 control mice, **p	 0.01). In C, F, G, and K, data are represented as mean
SEM. Scale bars: (in E) D, E, 30m; (in J) I, J, 50m.







Ret CKO Control Ret CKO Control
III Tubulin nd nd 32 2.1** 46.7 2.5
TrkA 25 5.8* 9.3 2.2 22.1 4.3* 10 2.6
GFR2 67.7 0.6 72.9 4.5 71.7 1.5*** 94.2 1.1
GFR3 14.3 1.1** 6.6 1.3 13.5 1.9** 6.0 0.9
n3of eachgenotype forIII tubulin andGfr2, and4of eachgenotype for TrkA. ForGfr3,n4Ret-Nav1.8CKO
mice and 5 control mice. *p 0.05; **p	 0.01; ***p	 0.001.
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Nav1.8 expression in Gfr3-positive neu-
rons, because Gfr3 is expressed exclu-
sively in small-diameter DRG neurons
(Orozco et al., 2001; Elitt et al., 2006) and
Nav1.8 is expressed in nearly all small-
diameter DRG neurons (Stirling et al.,
2005), suggesting significant overlap of
Nav1.8 and Gfr3 expression. Deletion
of Ret results in an increase in the pro-
portion of Gfr3-positive neurons that
are EGFP-positive (Fig. 3 J,K, Table 2),
suggesting that Ret negatively regulates
Gfr3 expression in small-diameter DRG
neurons.
Ret deletion decreases peripheral but
not central afferent density of
nonpeptidergic nociceptors
To determine whether neuron loss due
to Ret deletion is accompanied by a corre-
sponding loss of peripheral innervation,
we quantified the density of EGFP-posi-
tive fibers in the epidermis (Fig. 4A,D,G).
Labeling with an anti-EGFP antibody was
required to visualize EGFP afferents in
the skin. The density of EGFP-positive
sensory afferents in the epidermis of
Ret-Nav1.8 CKO mice is significantly de-
creased compared with Ret-Nav1.8 Het
control mice. This decrease in nonpepti-
dergic afferents in the epidermis likely re-
flects the loss of nonpeptidergic neurons.
Surprisingly, the total epidermal fiber
density, as determined by the density of
III tubulin-positive fibers, is not signifi-
cantly different in Ret-Nav1.8 CKO mice
from that in Ret-Nav1.8 Het control mice (Fig. 4B,E,G). The
majority of nerve fibers in the epidermis are fromnonpeptidergic
DRGneurons that express Ret or fromDRGneurons that express
the NGF receptor TrkA and coexpress neuropeptides (Zylka et
al., 2005). To determine whether expansion of the TrkA/pepti-
dergic fiber population in the epidermis accounts for the normal
number of III tubulin-labeled fibers observed in Ret-Nav1.8
CKO mice, we compared the density of CGRP-positive fibers in
Ret-Nav1.8 CKO mice and Ret-Nav1.8 Het control mice (Fig.
4C,F,G). We found that there is no difference in the density of
CGRP-positive fibers in the epidermis of Ret-Nav1.8 CKO and
control mice, indicating that expansion of peptidergic afferents
does not account for the normal density of III tubulin-labeled
epidermal afferents observed in Ret-Nav1.8 CKO mice.
In the spinal cord dorsal horn, TrkA (peptidergic) and Ret
(nonpeptidergic) afferents are segregated with TrkA afferents oc-
cupying lamina I and lamina IIo and Ret afferents occupying
lamina IIi (Molliver et al., 1997). Double labeling of EGFP (Ret)
and CGRP (TrkA) afferents in the lumbar dorsal horn shows that
the non-overlapping pattern of Ret and TrkA afferents observed
in lamina I and lamina II of Ret-Nav1.8Het control mice is indis-
tinguishable from the pattern observed in Ret-Nav1.8 CKOmice
(Fig. 5A–F). In addition, the density of EGFP labeling in Ret-
Nav1.8 CKO mice is similar to Ret-Nav1.8 Het control mice, in-
dicating that, in contrast to peripheral projections, the density of
the central projections of nonpeptidergic Ret afferents is unchanged
in the absence of Ret. Similar results were obtained with higher di-
lution of the GFP antibody, suggesting that oversaturation of the
fluorescent signal did not obscure loss of EGFP-positive afferents
(data not shown). IB4 labeling of nonpeptidergic afferents in the
lumbar dorsal horn was also similar inRet-Nav1.8CKOmice and
Ret-Nav1.8Het controlmice (see Fig. 8F,G). Therefore, although
there is a significant loss of nonpeptidergic neurons inRet-Nav1.8
CKOmice, the density and topography of the central projections
of these neurons in the dorsal horn appear normal. Ret signaling
is therefore dispensable for the development andmaintenance of
central projections from nonpeptidergic DRG neurons, since
surviving nonpeptidergic neurons reach their central targets in
the absence of Ret.
Ret-Nav1.8 CKOmice have normal responses to mechanical
stimuli and noxious heat
To determine whether loss of Ret in nociceptors affects mechan-
ical sensitivity, von Frey testing was performed on Ret-Nav1.8
CKO and control mice. There is no difference in hindpaw me-
chanical sensitivity between Ret-Nav1.8 CKO mice and control
mice (Fig. 6A, left). Sensitivity to a noxiousmechanical stimulus,
determined using a modified Randall–Selitto test, is also not dif-
ferent in Ret-Nav1.8 CKO mice from that in control mice (Fig.
6A, right). These results indicate that Ret signaling in nonpepti-
dergic DRG neurons is not required for normal behavioral sen-
sitivity to innocuous or noxious mechanical stimuli. Recent
reports demonstrating increased mechanical thresholds in mice
in which most/all nonpeptidergic DRG neurons are killed using

































Figure 4. The density of nonpeptidergic fibers is decreased in the epidermis of Ret-Nav1.8 CKO mice. The density of EGFP-
positive fibers (A, D, G) in the epidermis is significantly decreased in Ret-Nav1.8 CKOmice (D) compared to Ret-Nav1.8 Het control
mice (A) (n 4 for each genotype, **p	 0.005). Total epidermal innervation, asmeasured by the density ofIII tubulin-positive
fibers (B, E, G), is not different in Ret-Nav1.8 CKOmice (E) from that in Ret-Nav1.8 Het controls (B) (n 8 for each genotype). The
density of CGRP-positive fibers (C, F,G) is also not different in Ret-Nav1.8 CKOmice (F ) from that in Ret-Nav1.8Het controlmice (C)
(n 7 for each genotype). In G, data are represented as mean SEM. Scale bar: (in F) A–F, 50m.
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diphtheria toxin (DTA) suggest that nonpeptidergic nociceptors
are required for normal mechanical sensitivity (Abrahamsen et
al., 2008; Cavanaugh et al., 2009). In Ret-Nav1.8 CKO mice in
which 
50% of nonpeptidergic DRG neurons are lost, we ob-
served no change in mechanical sensitivity, indicating that 50%
or less of the normal number of non-peptidergic DRG neurons is
sufficient to maintain normal mechanical sensitivity.
Previous studies suggest that GFL/Ret signaling may modu-
late noxious heat transduction in IB4 nociceptors (Stucky et al.,
2002; Lindfors et al., 2006). We found that noxious heat sensitiv-
ity, as measured by the Hargreaves test, is not different between
Ret-Nav1.8 CKO and control mice (9.2  0.5 s, 8.8  0.3 s,
respectively; p 0.4; Ret-Nav1.8 CKO, n 25, control, n 55).
Consistent with this finding, qRT-PCR analysis reveals no change
in the expression of the noxious heat-activated channelTRPV1 in
Ret-Nav1.8 CKO mice compared to control mice (Table 1). Be-
cause male and female mice respond differently to noxious ther-
mal stimuli (Mogil et al., 2000), we analyzed data frommale and
female mice separately. There was no difference between Ret-
Nav1.8 CKO and control mice in the male or female group (Fig.
6B). As previously reported, male control mice had significantly
longer withdrawal latencies than female control mice (Mogil et
al., 2000). Thermal preference, measured using a thermal gradi-
ent apparatus, was not different in male or female Ret-Nav1.8
CKO from that in controlmice (supplemental Fig. S1, available at
www.jneurosci.org as supplemental material).
Ret-Nav1.8 CKOmice show increased
sensitivity to cold (acetone)
Todeterminewhether Ret loss in nonpep-
tidergic nociceptors influences sensitivity
to a cold stimulus, we assessed cold sen-
sitivity in Ret-Nav1.8 CKOmice and con-
trol mice using the acetone test. Female
Ret-Nav1.8CKOmice respond to a signif-
icantly greater percentage of acetone ap-
plications than female control mice (Fig.
6C). In addition, the total amount of time
spent in pain-like behavior is significantly
greater for female Ret-Nav1.8 CKO mice
than for female controls (Fig. 6D). In con-
trast, male Ret-Nav1.8 CKO mice are not
different from male control mice (Fig.
6C,D). This result suggests that disruption
of Ret signaling in nonpeptidergic DRG
neurons in female Ret-Nav1.8 CKO mice
results in greater sensitivity to cold and is
consistent with the observation that a
mixed group of male and female Gfr2-
null mice show increased sensitivity to
cold (Lindfors et al., 2006). In addition,
our findings suggest that cold sensitivity
may be influenced by gender. This possi-
bility is consistent with a recent report of
gender-based differences in cold sensi-
tivity in TRPA1-null mice (Kwan et al.,
2006).
Our results suggest that Ret signaling
in nonpeptidergic nociceptors regulates
cold sensation. Alternatively, loss of non-
peptidergic neurons could contribute to
increased cold sensitivity in Ret-Nav1.8
CKOmice. However, this possibility is in-
consistent with recent reports in which
DTA is used to kill specific subpopulations of DRG neurons and
cold sensitivity is either abolished or unchanged (Abrahamsen et
al., 2008; Cavanaugh et al., 2009). Examination of the expression
of the cold-activated channels TRPA1 and TRPM8 in Ret-Nav1.8
CKO by qRT-PCR reveals a significant increase only in TRPM8
expression in Ret-Nav1.8 CKO mice compared to control mice
(Table 1). This result suggests that Ret signaling normally sup-
presses the expression of TRPM8 and that themechanism under-
lying increased cold sensitivity in Ret-Nav1.8 CKO mice may
involve TRPM8. Previous reports indicating that TRPM8 is not
colocalized with Nav1.8 (Abrahamsen et al., 2008) or IB4 (Dhaka
et al., 2008) suggest that TRPM8 and Ret are not colocalized and
may indicate that modulation of TRPM8 expression by Ret is
indirect.
Ret-Nav1.8 CKOmice exhibit increased pain behavior in the
formalin test
We performed the formalin test in Ret-Nav1.8 CKO and control
mice to determine whether deletion of Ret in small-diameter
DRG neurons affects spontaneous pain behavior induced by in-
flammation. Ret-Nav1.8 CKO mice have an increased response,
compared to control mice, in both phases of the formalin test
(Fig. 7). In the first phase of the formalin test, Ret-Nav1.8 CKO
mice spent 25% more time engaged in spontaneous pain behav-
ior than controlmice. In the second phase,Ret-Nav1.8CKOmice
spent 








Figure5. Thedensity and topographyof the central projections of nonpeptidergic nociceptors appear normal inRet-Nav1.8CKO
mice. The density and topography of the central projections from nonpeptidergic DRG neurons in the superficial laminae of the
lumbar dorsal horn of Ret-Nav1.8 CKOmice (A, C, E) are not changed comparedwith Ret-Nav1.8 Het control mice (B,D, F ). Photos
are representative of four mice of each genotype. Scale bar: (in F) A–F, 50m.
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than control mice. These data suggest that
Ret signaling in nociceptors attenuates
formalin-induced inflammatory pain.
Our results are contrary to the de-
creased formalin-induced pain behavior
observed in Gfr2-null mice. Although
decreased cell size suggests Ret signaling is
decreased in Gfr2-null mice (Lindfors et
al., 2006), it is not known to what extent
Ret signaling is impaired in Gfr2-null
mice, since many sensory neurons ex-
press more than one Gfr coreceptor.
In addition, Ret-Nav1.8 CKO mice ex-
hibit cell loss and changes in peripheral
innervation, which are different from
anatomical changes observed in Gfr2-
null mice. Gfr2-null mice also are re-
ported to be severely growth retarded,
which could influence pain behavior.
Therefore, it is not surprising that the
phenotypes of these two mutant mice
are not identical.
Sensorimotor andmotor function is
not altered in Ret-Nav1.8 CKO mice
To ensure that behavioral changes ob-
served in Ret-Nav1.8 CKO are sensory
specific and are not related to distur-
bances of general sensorimotor func-
tion or to motor deficits, we performed
sensorimotor testing in Ret-Nav1.8 CKO
mice and control mice. The performance
of Ret-Nav1.8 CKO mice is not different
from Ret control mice in any of these
tests (supplemental Figs. S1, S2, available
at www.jneurosci.org as supplemental
material).
TrkA expression is not increased in Ret-Nav1.8 CKO mice
NGF is a well established mediator of inflammation and attenu-
ation of NGF/TrkA signaling decreases inflammation-induced
pain behavior in the formalin test (Pezet and McMahon, 2006;
Ugolini et al., 2007). Expanded TrkA expression could therefore
explain the enhanced response to formalin observed in Ret-
Nav1.8 CKO mice. We examined TrkA expression in sensory
neurons from which Ret is deleted to determine whether TrkA
expression is expanded in this population. In control mice, we
found that TrkA is coexpressed in 9.3  2.2% of DRG neurons
that express Ret (EGFP-positive neurons), consistent with previ-
ous reports (Table 2) (Molliver et al., 1997). There is an increase
in the percentage of EGFP-positive neurons that coexpress TrkA
in Ret-Nav1.8 CKOmice compared with Ret-Nav1.8Het control
mice (Fig. 8A–C, left, Table 2). The increase in TrkA coexpres-
sion in EGFP-positive neurons could be a result of expansion of
TrkA expression in the nonpeptidergic population of nociceptors
ormay reflect the decreased number of EGFP-positive neurons in
Ret-Nav1.8 CKO mice. Quantification of the total number of
TrkA-positive neurons in lumbar DRG revealed that the total
number of TrkA-positive neurons is not different in Ret-Nav1.8
CKO mice from that in Ret-Nav1.8 Het control mice (Fig. 8C,
right). Although the total number of TrkA-positiveDRGneurons
is not significantly altered in Ret-Nav1.8 CKO, the proportion of
TrkA-positive nociceptors is increased due to loss of nonpepti-
dergic nociceptors in Ret-Nav1.8 CKO mice. An increase in the
proportion of “proinflammatory” TrkA nociceptors may con-
tribute to increased inflammation-induced pain observed in Ret-
Nav1.8 CKO mice.
Reduced TMP activity in Ret-Nav1.8 CKO mice
TMP is a well known marker for nonpeptidergic DRG neurons
and is known to colocalize extensively with IB4 (Bennett et al.,
1998b; Zylka et al., 2008). A recent report has identified TMP as
the transmembrane form of PAP, an enzyme that dephosphory-
lates extracellular AMP to produce the analgesic molecule aden-
osine (Zylka et al., 2008). PAP-null mice show normal sensitivity
tomechanical and noxious thermal stimuli but are hypersensitive
in chronic inflammatory and neuropathic pain models. The ex-
pression of PAP specifically in nonpeptidergic DRG neurons and
the similar behavior phenotypes of PAP-null mice and Ret-
Nav1.8 CKO mice suggested the possibility that Ret signaling
might influence PAP expression or activity. We performed TMP
histochemistry and found that TMP staining is greatly reduced in
the superficial laminae of the lumbar dorsal horn of Ret-Nav1.8
CKOmice compared with Ret-Nav1.8Het control mice, suggest-
ing that Ret modulates TMP expression and/or activity (Fig.
8D,E). Since the central projections of nonpeptidergicDRGneu-
rons are apparently normal inRet-Nav1.8CKOmice as shown by


























































































Figure 6. Ret-Nav1.8 CKOmice have normal responses to mechanical and noxious heat stimuli but are hypersensitive to a cold
stimulus.A, Mechanical sensitivity is not changed in Ret-Nav1.8 CKOmice compared to controlmice. Left, von Frey, Ret-Nav1.8 CKO
mice, n 10; control mice n 17. Right, Randall–Selitto, n 14 of each genotype. B, Noxious heat sensitivity is unchanged in
female and male Ret-Nav1.8 CKO mice compared with female and male control mice (females: Ret-Nav1.8 CKO mice, n 11;
control,n38;males:Ret-Nav1.8 CKOmice,n8; control,n17). FemaleRet-Nav1.8 CKOand controlmice have a significantly
shorter withdrawal latency thanmale Ret-Nav1.8 CKO and control mice (female vsmale Ret-Nav1.8 CKOmice, p	 0.05; female vs
male control,p	0.000001).C,D, FemaleRet-Nav1.8 CKOmice are hyper-responsive to acetone compared to female controlmice.
C, Female Ret-Nav1.8 CKOmice (n 11) respond to a significantly greater percentage of acetone applications than female control
mice (n 24) (**p	 0.001). Male Ret-Nav1.8 CKOmice (n 10) are not different frommale controls (n 18) in percentage of
responses to acetone applications. Female control mice (n 24) respond to a significantly lower percentage of acetone applica-
tions thanmale controlmice (n18) (*p	0.05).D, FemaleRet-Nav1.8CKOmice (n7) spend significantlymore timeengaged
in pain behavior than female controlmice (n 11) following acetone application (*p 0.05).Male Ret-Nav1.8 CKOmice (n 4)
are not different frommale control mice (n 9) in the amount of time spent in pain behavior. Female control mice (n 11) are
not different frommale control mice (n 9) in the amount of time spent in pain behavior. Data are represented asmean SEM.
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decrease in TMP staining is due to loss of nonpeptidergic affer-
ents in the dorsal horn. Using qRT-PCR, we found that PAP
expression is significantly decreased in lumbar DRG from Ret-
Nav1.8 CKO mice compared to control mice (Table 1). These
results are consistent with the possibility that Ret positively reg-
ulates PAP expression and/or activity and that loss of Ret in non-
peptidergic nociceptors results in a decrease in PAP with a
consequent increase in formalin-induced pain.
Discussion
Specific deletion of Ret in nonpeptidergic nociceptors of Ret-
Nav1.8CKOmice has, for the first time, provided an opportunity
to examine the physiological function of GFL/Ret signaling in
nonpeptidergic nociceptors in mature mice. Our results demon-
strate that Ret is required for the survival, trophic support, and
normal function of nonpeptidergic nociceptors and provide evi-
dence that decreased PAP expression or activity may be the mo-
lecular mechanism underlying increased formalin-induced pain
following Ret deletion in nociceptors.
Ret signaling is required for survival of
nonpeptidergic nociceptors
Ret expression increases from embryonic day 17 to PND 7 in
maturing nonpeptidergic DRG neurons, while TrkA expression
is extinguished between PND 0 and PND 21 (Molliver et al.,
1997). A recent study in which Ret was conditionally deleted in
DRG neurons using Wnt1-Cre reported that Ret is required for
TrkA extinction in nonpeptidergic neurons (Luo et al., 2007). In
contrast, we found that TrkA expression is not maintained in
nonpeptidergic neurons in adult Ret-Nav1.8 CKO mice. Al-
though the rate of TrkA extinction is decreased inRet-Wnt1CKO
mice, TrkA expression is significantly decreased during the first
two postnatal weeks in these mice (Luo et al., 2007), suggesting
that, in agreement with our results, TrkA extinction occurs in
nonpeptidergic DRG neurons in the absence of Ret. In addition,
extinction of TrkA expression in nonpeptidergic DRG neurons is
reportedly not complete until PND 21 (Molliver et al., 1997).
Since Ret-Wnt1 CKO mice die in the third postnatal week it was
not possible to determine whether TrkA extinction continues
after P14 or whether TrkA extinction is completed in these mice.
Deletion of Ret in nonpeptidergic nociceptors in Ret-Nav1.8
CKOmice results in
50% loss of these neurons. Although GFL/
Ret signaling is reported to influence sensory neuron survival



















































Figure 7. Ret-Nav1.8 CKO mice exhibit increased formalin-induced pain behavior. Ret-
Nav1.8 CKO (n 9)mice show increased sensitivity to formalin compared to controlmice (n
11).A, Timecourseof spontaneouspainbehavior following intraplantar injectionof formalin.B,
Total time spent in spontaneous pain behavior in phase 1 (5–10min) andphase 2 (10–60min)
of the formalin test. Ret-Nav1.8 CKOmice are different from control mice in both phases (phase



















































Figure8. Thenumberof TrkA-positiveneurons is unchanged in lumbarDRG fromRet-Nav1.8
CKO and TMP (PAP) expression is decreased in the dorsal horn of the spinal cord of Ret-Nav1.8
CKO mice. The percentage of EGFP-positive neurons that coexpress TrkA is increased in Ret-
Nav1.8 CKOmice (B, C, left) compared with Ret-Nav1.8 Het control mice (A, C, left) (*p	 0.05,
n 4 of each genotype). Arrows indicate EGFP/TrkA double-labeled neurons. C, Right,
The total number of TrkA-positive neurons is not different in Ret-Nav1.8 CKO mice from that in
Ret-Nav1.8 Het control mice (n 4 of each genotype). D, E, TMP (PAP) is decreased in the
superficial laminae of the dorsal horn of the spinal cord in Ret-Nav1.8 CKO mice (E) compared
with Ret-Nav1.8Het controlmice (D). IB4 labeling is the same in Ret-Nav1.8Het control (F ) and
Ret-Nav1.8 CKO mice (G). Images shown in D and E are representative of eight mice of each
genotype, F and G are representative of 6 mice of each genotype. In C, data are represented as
mean SEM. Scale bars: B (for A, B), G (for D–G), 50m.
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under various experimental conditions (Matheson et al., 1997;
Airaksinen and Saarma, 2002; Zwick et al., 2002; Elitt et al., 2006),
the role of endogenous GFL/Ret signaling in sensory neuron sur-
vival in mature animals is unclear. Analysis of GFL- and GFL
coreceptor-null mice has produced inconsistent results (Airaksinen
and Saarma, 2002) due to overlapping expression of Gfr core-
ceptors in many DRG neurons (Bennett et al., 1998b). Determi-
nation of neuron numbers in mice in which Ret is deleted has
overcome this confound, since Ret partners with all of the GFL
coreceptors.
The incomplete loss of nonpeptidergic DRG neurons in Ret-
Nav1.8 CKOmice suggests that a subpopulation of nonpeptider-
gic neurons is not dependent on Ret signaling for survival. DRG
neurons become increasingly independent of trophic factors for
survival during the first three postnatal weeks, the same period
during which the transition from TrkA to Ret expression occurs
in nonpeptidergic neurons (Molliver et al., 1997; Vogelbaum et
al., 1998). During the transition from TrkA to Ret expression, a
subpopulation of nonpeptidergic neurons coexpresses both re-
ceptors, raising the possibility that nonpeptidergic neurons that
downregulate TrkA late in postnatal development depend on
NGF/TrkA signaling for survival in the absence of Ret. In support
of this possibility, before TrkA extinction in nonpeptidergicDRG
neurons, NGF can support the survival of these neurons in vitro
(Molliver et al., 1997), suggesting that NGF/TrkA signaling can
substitute for GFL/Ret signaling to maintain survival of nonpep-
tidergic neurons. Neurons that lose TrkA expression early in the
period of transition when they are still trophic factor-dependent
likely die in Ret-Nav1.8 CKO because they lack both Ret and
TrkA.
DRG neuron loss was not observed at PND 14 in Ret-Wnt1
CKO mice, suggesting that DRG neuron survival is not depen-
dent on Ret (Luo et al., 2007). However, at P14 TrkA extinction is
not yet complete in nonpeptidergic neurons (Molliver et al.,
1997). Nonpeptidergic neurons that continue to express TrkA at
PND 14 could survive through NGF/TrkA signaling in the ab-
sence of Ret. There may be a subpopulation of DRG neurons lost
by PND14 in Ret-Wnt1 CKO mice (likely those that downregu-
late TrkA before PND 14) that is too small to detect.
Central and peripheral projections of nonpeptidergic DRG
neurons in Ret-Nav1.8 CKOmice
Surprisingly, the density of central projections of nonpeptidergic
nociceptors appears normal in adult animals despite significant
loss of nonpeptidergic DRG neurons in Ret-Nav1.8 CKO mice.
One possible explanation for this observation is that surviving
nonpeptidergic neurons elaborate additional collateral branches
in the dorsal horn to compensate for afferents that are lost with
dying neurons. Whether or not these branches form appropriate
central connections is unknown and could impact functional
changes observed in Ret-Nav1.8 CKO mice.
Loss of nonpeptidergic afferents in the epidermis is consistent
with the loss of nonpeptidergic neurons observed in Ret-Nav1.8
CKOmice. Development of epidermal innervation is dependent
on NGF/TrkA signaling and independent of GFL/Ret signaling
(Molliver et al., 1997; Patel et al., 2000). Whether the mainte-
nance of peripheral innervation by nonpeptidergic neurons re-
quires GFL/Ret signaling in mature mice is unknown. Although
50% of nonpeptidergic DRG neurons are lost,
30% of the epi-
dermal innervation density from nonpeptidergic fibers is main-
tained in Ret-Nav1.8 CKO mice, suggesting that the majority of
surviving nonpeptidergic neuronsmaintain target innervation in
the absence of GFL/Ret signaling. This indicates that GFL/Ret
signaling is not invariably required for the maintenance of pe-
ripheral target innervation, although a subpopulation of surviv-
ing nonpeptidergic neuronsmay depend on Ret for maintenance
of peripheral projections. Interestingly, NGF/TrkA signaling is
required for the maintenance of peptidergic/TrkA fiber innerva-
tion of the epidermis in mature animals (Bennett et al., 1998a),
revealing diverse requirements for trophic factors in the mainte-
nance of peripheral projections in peptidergic and nonpeptider-
gic nociceptors in mature animals.
Surprisingly, total epidermal fiber density is not decreased in
Ret-Nav1.8 CKOmice. Maintenance of normal epidermal inner-
vation density inRet-Nav1.8CKOmice is not due to expansion of
TrkA/peptidergic afferents or to increased branching of surviving
nonpeptidergic afferents. Because innervation density is regu-
lated by the amount of available trophic factor in the target field
(Kessler et al., 1983; Zwick et al., 2002; Elitt et al., 2006), other
Ret-expressing axons that respond to GFLs in the skin could
potentially extend into areas of the epidermis from which non-
peptidergic fibers are lost, leaving unoccupied target areas of
epidermis with available GFLs. Although peptidergic and non-
peptidergic fibers from small-diameterDRGneurons account for
the majority of nerve fibers in the epidermis, other fiber types are
present (Rice et al., 1998). Some of these, such as sympathetic
fibers, express Ret (Airaksinen and Saarma, 2002) and may ex-
pand in the epidermis of Ret-Nav1.8 CKO mice.
Ret-Nav1.8 CKOmice exhibit increased formalin-induced
pain
Ret-Nav1.8 CKO mice exhibit increased formalin-induced pain
behavior, suggesting that endogenous Ret signaling in nonpepti-
dergic nociceptors attenuates inflammation-induced pain. TMP,
a well knownmarker of nonpeptidergic nociceptors, was recently
identified as the transmembrane form of PAP (Zylka et al., 2008).
PAP expressed on the terminals of nonpeptidergic nociceptors in
lamina II of the dorsal horn dephosphorylates extracellular AMP
to produce the analgesic molecule adenosine, which activates
adenosine A1 receptors on lamina II neurons, producing an anti-
nociceptive effect in models of neuropathic and inflammatory
pain (Zylka et al., 2008).
The Ret ligands GDNF (Boucher et al., 2000), ARTN (Gardell
et al., 2003), and NRTN (our unpublished data) have potent
analgesic activity in nerve-injury models of neuropathic pain.
Exogenous GDNF restores TMP activity in nonpeptidergic DRG
neurons following nerve injury (Bennett et al., 1998b). The iden-
tification of the analgesic activity of PAP in nerve injury-induced
pain suggests that regulation of PAP expression or activitymay be
amechanismbywhichGFLs produce analgesia after nerve injury.
In addition, PAP has analgesic activity in a model of infla-
mmation-induced pain (Zylka et al., 2008). We found that PAP
activity is markedly reduced in the dorsal horn of Ret-Nav1.8
CKO mice (Fig. 8). Our findings suggest that regulation of PAP
may be a mechanism by which endogenous GFL/Ret signaling in
nonpeptidergic nociceptors modulates inflammation-induced
pain behavior.
Previously published studies provide conflicting information
as to whether GFLs are proalgesic or analgesic. A number of
studies have found that exogenous GFLs administered to nerve-
injured animals prevent or reverse neuropathic pain (Boucher et
al., 2000; Gardell et al., 2003; Hao et al., 2003; Wang et al., 2003;
Pezet et al., 2006). However, there are conflicting reports regard-
ing the effects of exogenous GFLs administered to normal ani-
mals. There have been reports that subcutaneous administration
of GFLs produces sensitization to noxious stimuli (Malin et al.,
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2006; Bogen et al., 2008). However, other studies have reported
that subcutaneous administration of GFLs does not alter sensory
thresholds (Boucher et al., 2000; Gardell et al., 2003; Hao et al.,
2003). Here, we focused on the role of endogenous GFL/Ret sig-
naling in nociceptors in inflammation-induced pain. Our find-
ings suggest that endogenous GFL/Ret signaling in nociceptors
attenuates inflammation-induced spontaneous pain. We pro-
pose that increased inflammation-induced spontaneous pain in
Ret-Nav1.8 CKO mice may be due to decreased PAP activity in
these mice. This hypothesis is based on the reported analgesic
action of PAP in models of both inflammatory and neuropathic
pain (Zylka et al., 2008). Our results do not address the possibility
that exogenous GFLs do or do not produce hyperalgesia in nor-
mal animals. Together with previous studies, our results suggest
that modulation of PAP activity may be a mechanism by which
GFL/Ret signaling produces analgesia in both inflammation- and
nerve injury-induced pain models.
In summary, our results demonstrate that Ret signaling is
required for the survival of a subpopulation of small-diameter
nonpeptidergic sensory neurons but is dispensable for the devel-
opment and maintenance of central and peripheral target inner-
vation of surviving nonpeptidergic neurons. Importantly, Ret
deletion in nonpeptidergic DRG neurons results in altered cold
sensitivity and increased pain following formalin-induced in-
flammation, indicating that Ret signaling modulates nociceptor
function in vivo.
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